SENORES PHARMACEUTICALS L (SENORES) Share Price rises 5.77% today to Rs 1,399
- September 7, 2026
- Posted by: Kunal Singla
- Category: News
SENORES Share Price is trading at Rs 1,399, up 5.77% today, with market capitalisation of Rs 6,212.63 crore. The move places SENORES Share Price among the notable risers in the healthcare pack today. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established. Even so, the latest SENORES Share Price move matters because it changes the near-term trading setup and places the stock’s valuation and operating metrics back under review. For readers tracking SENORES Share Price Today, the key question is not only how far the stock moved, but what the latest price action says when measured against earnings, book value and healthcare sector benchmarks. Univest data shows the stock is now trading well above the prior close, while the first-hour range already captures the day’s active price discovery. SENORES Share Price News therefore centres on verified movement, not speculation.
SENORES Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,399 |
| Previous Close | Rs 1,322.7 |
| Today's Move | Rs 76.3 (+5.77%) |
| Open | Rs 1,318.05 |
| High | Rs 1,399.75 |
| Low | Rs 1,318.05 |
| Market Capitalisation | Rs 6,212.63 crore |
| Market Cap Category | Mid Cap |
SENORES PHARMACEUTICALS L (SENORES) rose to Rs 1,399 from the previous close of Rs 1,322.7, a move of Rs 76.3 or 5.77%. The stock opened at Rs 1,318.05, reached a high of Rs 1,399.75, recorded a low of Rs 1,318.05.
SENORES Share Price is trading higher by Rs 76.30, or 5.77%, after moving from Rs 1,322.70 to Rs 1,399. The stock opened at Rs 1,318.05, touched a low of Rs 1,318.05 and reached a high of Rs 1,399.75. That places SENORES Share Price very close to the day’s high while remaining anchored to the morning’s opening band. For SENORES Share Price Today, the important verified facts are the gap between the previous close and the current quote, and the narrow distance between the last traded price and the day’s high. As of 06 October 2026 at 3:32:29 PM IST, the move is a clear share price rise within the ongoing session. SENORES Share Price Live readers should note that this is price action only; the next section places the move alongside the company’s financial metrics.
SENORES PHARMACEUTICALS L (SENORES) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 6,212.63 crore |
| P/E Ratio | 48.2x |
| P/B Ratio | 6.32x |
| ROE | 14.14% |
| ROCE | 15.66% |
| EPS | Rs 27.44 |
| Book Value Per Share | Rs 209.27 |
| Dividend Yield | 0% |
SENORES PHARMACEUTICALS L (SENORES) fundamental metrics show P/E 48.2x, P/B 6.32x, ROE 14.14%, ROCE 15.66%. These figures provide context only and are not a buy or sell signal.
SENORES PHARMACEUTICALS L has a market capitalisation of Rs 6,212.63 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 48.2x, P/B at 6.32x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 14.14% and ROCE of 15.66%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 27.44, book value per share of Rs 209.27, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.79x, median ROE of 11.73%, median ROCE of 13.63%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 48.2x |
| Benchmark Median P/E | 31.79x |
| Benchmark Average P/E | 47.98x |
| Benchmark P/E Range | 3.58x to 668.09x |
| Company P/B Ratio | 6.32x |
| Benchmark Median P/B | 2.9x |
| Company ROE | 14.14% |
| Benchmark Median ROE | 11.73% |
| Company ROCE | 15.66% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 6,212.63 crore |
| Benchmark Median Market Cap | Rs 812.84 crore |
SENORES PHARMACEUTICALS L (SENORES) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
SENORES PHARMACEUTICALS L (SENORES) has a P/E ratio of 48.2x, which is above the benchmark median of 31.79x, a difference of +51.62%. On its own, the P/E gap is a valuation reference point, not a trading call.
SENORES PHARMACEUTICALS L (SENORES) has a ROE of 14.14%, which is above the benchmark median of 11.73%, a difference of +20.55%. SENORES PHARMACEUTICALS L (SENORES) has a ROCE of 15.66%, which is above the benchmark median of 13.63%, a difference of +14.89%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,34,279.63 | 35.35 | 4.94 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,46,737.12 | 83.61 | 13.85 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,81,129.27 | 82.93 | 20.15 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,14,239.13 | 25.16 | 4.21 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,08,808.05 | 31.97 | 3.07 | 11.83 | 16 |
SENORES PHARMACEUTICALS L (SENORES) has a P/E ratio of 48.2x compared with the displayed peer median of 35.35x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 14.14% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 15.66% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. SENORES PHARMACEUTICALS L (SENORES) has a market capitalisation of Rs 6,212.63 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching SENORES
- SENORES Share Price is up 5.77% today, making it one of the clearer share price gain stories in healthcare.
- The stock is trading near the day’s high, which keeps SENORES Share Price in focus during the ongoing session.
- Valuation remains important, because SENORES Share Price trades at a P/E of 48.2 and a P/B of 6.32.
- ROE of 14.14% and ROCE of 15.66% give SENORES Share Price a measurable profitability base.
- Healthcare sector benchmarking shows SENORES Share Price above the industry median on P/E, P/B, ROE and ROCE.
About SENORES
SENORES PHARMACEUTICALS L operates in Healthcare and the Pharmaceuticals & Drugs industry. The current SENORES Share Price reflects a listed business that is being valued by the market at Rs 6,212.63 crore. On the numbers available today, SENORES Share Price is linked to earnings per share of Rs 27.44 and book value of Rs 209.27, which are useful for understanding the company’s per-share fundamentals. The dividend yield is 0%, so the stock does not currently present itself as a yield-led story. SENORES Share Price therefore sits in a space where traders and investors are likely to focus on valuation, earnings support and sector comparison rather than income. In Univest stock analysis, the company belongs to a broad pharmaceutical universe where peer differentiation often comes from margins, profitability ratios and how the market prices future earnings.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is SENORES Share Price rising today?
Ans. SENORES Share Price is up 5.77% today, but no company-specific catalyst is established. The verified move is clear, and the session range shows the stock trading near its high at Rs 1,399.75.
What is SENORES Share Price today?
Ans. SENORES Share Price is trading at Rs 1,399. It is higher by Rs 76.30 versus the previous close of Rs 1,322.70, making today’s share price rise a notable move in the healthcare space.
What is SENORES Share Price Today compared with the previous close?
Ans. SENORES Share Price Today is above the previous close by 5.77%. The stock opened at Rs 1,318.05 and moved to a high of Rs 1,399.75 during the ongoing session.
How is SENORES Share Price valued on fundamentals?
Ans. SENORES Share Price is supported by EPS of Rs 27.44, book value of Rs 209.27, ROE of 14.14% and ROCE of 15.66%. Its P/E of 48.2 and P/B of 6.32 keep valuation in focus.
How does SENORES compare with the healthcare sector?
Ans. In the same-industry set of 198 companies, SENORES Share Price trades above the median on P/E, P/B, ROE and ROCE. That places the stock above typical industry benchmarks on several key metrics.
Which peers help compare SENORES Share Price?
Ans. Sun Pharma, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla provide useful peer context. SENORES Share Price sits below several larger pharma names on market cap, but it has a distinct valuation profile.
Does SENORES pay a dividend?
Ans. The dividend yield for SENORES is 0. That means SENORES Share Price should be viewed without an income contribution from dividends in the current set of figures.
Should investors track SENORES Share Price on Univest?
Ans. Yes. Univest tracks SENORES Share Price, fundamentals, market cap and healthcare-sector context in one place. That makes it easier to follow SENORES Share Price Today alongside verified valuation and peer data.
Track SENORES Share Price on Univest
Use SENORES PHARMACEUTICALS L (SENORES) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Track SENORES Share Price on Univest for live price updates, market cap tracking, fundamental ratios, 52-week levels and broader market insights. SENORES Share Price Today can be monitored alongside valuation measures and healthcare sector context, helping readers stay aligned with verified market movement. Univest brings the latest SENORES Share Price, SENORES Stock News and SENORES Stock Analysis together in one place, so the stock can be followed without relying on fragmented updates.
